A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

This new medication, unlike many existing treatments ... pain without causing harmful side effects. Chronic nerve pain, or neuropathic pain, is caused by damage to nerves outside the brain ...

Direct comparative studies are needed of the safety and efficacy of drugs used to treat neuropathic pain.

Summary: Pregabalin is the first drug to receive approved labeling ... Pregabalin has demonstrated efficacy in the management of neuropathic pain associated with diabetic peripheral neuropathy ...

In palliative care, we have a small number of parenteral medication options for the management of neuropathic pain; including sodium valproate, clonidine, methadone, ketamine and clonazepam.1 As a ...

I last wrote here several months ago about the sodium channel (NaV1.8) inhibitor VX-548 (now known as suzetrigine), which is ...

The small miracles that 2024 brought to our lives lay the groundwork for new revolutionary treatments that are being prepared ...

BHV-2100 is under clinical development by Biohaven and currently in Phase II for Neuropathic Pain (Neuralgia). According to GlobalData, Phase II drugs for Neuropathic Pain (Neuralgia) have a 32% phase ...

AFA-281 is under clinical development by AfaSci and currently in Phase I for Neuropathic Pain (Neuralgia). According to GlobalData, Phase I drugs for Neuropathic Pain (Neuralgia) have a 76% phase ...

A new study by Monash University medicine safety experts found the use of gabapentinoids—medicines widely used to treat ...

When a new 61-year-old female patient told me 10 years ago that her primary care physician referred her to me for treatment of her neuropathic pain in her legs due to her diabetes and feet, I was ...

1 Mech-Sense, Department of Gastroenterology, Aalborg University Hospital, Aalborg, Denmark 2 Center for Sensory-Motor Interactions, Department of Health Science and Technology, Aalborg University, ...